awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36929648-5DC362AE-BE95-4A32-A8FE-6E0028ADD319
Q36929648-5DC362AE-BE95-4A32-A8FE-6E0028ADD319
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36929648-5DC362AE-BE95-4A32-A8FE-6E0028ADD319
Emerging therapies in castrate-resistant prostate cancer.
P2860
Q36929648-5DC362AE-BE95-4A32-A8FE-6E0028ADD319
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36929648-5DC362AE-BE95-4A32-A8FE-6E0028ADD319
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
afda1d72bc196470e7258e01ac7966523f9b357d
P2860
Activity of second-line chemotherapy in docetaxel-refractory hormone-refractory prostate cancer patients : randomized phase 2 study of ixabepilone or mitoxantrone and prednisone.